{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:10:26Z","timestamp":1791051026296,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1124\/jpet.103.058818","type":"journal-article","created":{"date-parts":[[2004,1,27]],"date-time":"2004-01-27T23:33:16Z","timestamp":1075246396000},"page":"495-501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":182,"title":["Induction of Human CYP2C9 by Rifampicin, Hyperforin, and Phenobarbital Is Mediated by the Pregnane X Receptor"],"prefix":"10.1016","volume":"308","author":[{"given":"Yuping","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen S.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Negishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce A.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.103.058818_bib1","doi-asserted-by":"crossref","unstructured":"Ferguson SS, LeCluyse EL, Negishi M, and Goldstein JA (2002) Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site. Mol Pharmacol 62: 737\u2013746.","DOI":"10.1124\/mol.62.3.737"},{"key":"10.1124\/jpet.103.058818_bib2","doi-asserted-by":"crossref","unstructured":"Gerbal-Chaloin S, Daujat M, Pascussi JM, Pichard-Garcia L, Vilarem MJ, and Maurel P (2002) Transcriptional regulation of CYP2C9 gene. Role of glucocorticoid receptor and constitutive androstane receptor. J Biol Chem 277: 209\u2013217.","DOI":"10.1074\/jbc.M107228200"},{"key":"10.1124\/jpet.103.058818_bib3","unstructured":"Gerbal-Chaloin S, Pascussi JM, Pichard-Garcia L, Daujat M, Waechter F, Fabre JM, Carrere N, and Maurel P (2001) Induction of CYP2C genes in human hepatocytes in primary culture. Drug Metab Dispos 29: 242\u2013251."},{"key":"10.1124\/jpet.103.058818_bib4","doi-asserted-by":"crossref","unstructured":"Goldstein JA (2001) Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. Br J Clin Pharmacol 52: 349\u2013355.","DOI":"10.1046\/j.0306-5251.2001.01499.x"},{"key":"10.1124\/jpet.103.058818_bib5","doi-asserted-by":"crossref","unstructured":"Goldstein JA and de Morais SM (1994) Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacogenetics 4: 285\u2013299.","DOI":"10.1097\/00008571-199412000-00001"},{"key":"10.1124\/jpet.103.058818_bib6","doi-asserted-by":"crossref","unstructured":"Goodwin B, Hodgson E, and Liddle C (1999) The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol Pharmacol 56: 1329\u20131339.","DOI":"10.1124\/mol.56.6.1329"},{"key":"10.1124\/jpet.103.058818_bib7","doi-asserted-by":"crossref","unstructured":"Goodwin B, Moore LB, Stoltz CM, McKee DD, and Kliewer SA (2001) Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor. Mol Pharmacol 60: 427\u2013431.","DOI":"10.1016\/S0026-895X(24)12603-X"},{"key":"10.1124\/jpet.103.058818_bib8","doi-asserted-by":"crossref","unstructured":"Heimark LD, Gibaldi M, Trager WF, O\u2019Reilly RA, and Goulart DA (1987) The mechanism of the warfarin-rifampin drug interaction in humans. Clin Pharmacol Ther 42: 388\u2013394.","DOI":"10.1038\/clpt.1987.168"},{"key":"10.1124\/jpet.103.058818_bib9","doi-asserted-by":"crossref","unstructured":"Honkakoski P (2003) Drug-activated nuclear receptors CAR and PXR. Ann Med 35: 172\u2013182.","DOI":"10.1080\/07853890310008224"},{"key":"10.1124\/jpet.103.058818_bib10","doi-asserted-by":"crossref","unstructured":"Ibeanu GC and Goldstein JA (1995) Transcriptional regulation of human CYP2C genes: functional comparison of CYP2C9 and CYP2C18 promoter regions. Biochemistry 34: 8028\u20138036.","DOI":"10.1021\/bi00025a008"},{"key":"10.1124\/jpet.103.058818_bib11","doi-asserted-by":"crossref","unstructured":"Kawana K, Ikuta T, Kobayashi Y, Gotoh O, Takeda K, and Kawajiri K (2003) Molecular mechanism of nuclear translocation of an orphan nuclear receptor, SXR. Mol Pharmacol 63: 524\u2013531.","DOI":"10.1124\/mol.63.3.524"},{"key":"10.1124\/jpet.103.058818_bib12","doi-asserted-by":"crossref","unstructured":"Kay L, Kampmann JP, Svendsen TL, Vergman B, Hansen JE, Skovsted L, and Kristensen M (1985) Influence of rifampicin and isoniazid on the kinetics of phenytoin. Br J Clin Pharmacol 20: 323\u2013326.","DOI":"10.1111\/j.1365-2125.1985.tb05071.x"},{"key":"10.1124\/jpet.103.058818_bib13","doi-asserted-by":"crossref","unstructured":"Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, McKee DD, Oliver BB, Willson TM, Zetterstrom RH, Perlmann T, and Lehmann JM (1998) An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92: 73\u201382.","DOI":"10.1016\/S0092-8674(00)80900-9"},{"key":"10.1124\/jpet.103.058818_bib14","doi-asserted-by":"crossref","unstructured":"Lee CR, Goldstein JA, and Pieper JA (2002) Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data. Pharmacogenetics 12: 251\u2013263.","DOI":"10.1097\/00008571-200204000-00010"},{"key":"10.1124\/jpet.103.058818_bib15","doi-asserted-by":"crossref","unstructured":"Luo G, Cunningham M, Kim S, Burn T, Lin J, Sinz M, Hamilton G, Rizzo C, Jolley S, Gilbert D, Downey A, Mudra D, Graham R, Carroll K, Xie J, Madan A, Parkinson A, Christ D, Selling B, LeCluyse E and Gan LS (2002) CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes. Drug Metab Dispos 30: 795\u2013804.","DOI":"10.1124\/dmd.30.7.795"},{"key":"10.1124\/jpet.103.058818_bib16","doi-asserted-by":"crossref","unstructured":"Madan A, Graham RA, Carroll KM, Mudra DR, Burton LA, Krueger LA, Downey AD, Czerwinski M, Forster J, Ribadeneira MD, Gan LS, LeCluyse EL, Zech K, Robertson P Jr, Koch P, Antonian L, Wagner G, Yu L and Parkinson A (2003) Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. Drug Metab Dispos 31: 421\u2013431.","DOI":"10.1124\/dmd.31.4.421"},{"key":"10.1124\/jpet.103.058818_bib17","doi-asserted-by":"crossref","unstructured":"Maglich JM, Parks DJ, Moore LB, Collins JL, Goodwin B, Billin AN, Stoltz CA, Kliewer SA, Lambert MH, Willson TM, and Moore JT (2003) Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J Biol Chem 278: 17277\u201317283.","DOI":"10.1074\/jbc.M300138200"},{"key":"10.1124\/jpet.103.058818_bib18","doi-asserted-by":"crossref","unstructured":"Miners JO and Birkett DJ (1998) Cytochrome P4502C9: an enzyme of major importance in human drug metabolism. Br J Clin Pharmacol 45: 525\u2013538.","DOI":"10.1046\/j.1365-2125.1998.00721.x"},{"key":"10.1124\/jpet.103.058818_bib19","doi-asserted-by":"crossref","unstructured":"Moore JT and Kliewer SA (2000) Use of the nuclear receptor PXR to predict drug interactions. Toxicology 153: 1\u201310.","DOI":"10.1016\/S0300-483X(00)00300-0"},{"key":"10.1124\/jpet.103.058818_bib20","doi-asserted-by":"crossref","unstructured":"Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM, Collins JL, and Kliewer SA (2000a) St. John\u2019s wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA 97: 7500\u20137502.","DOI":"10.1073\/pnas.130155097"},{"key":"10.1124\/jpet.103.058818_bib21","doi-asserted-by":"crossref","unstructured":"Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM, Collins JL, and Kliewer SA (2000b) Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 275: 15122\u201315127.","DOI":"10.1074\/jbc.M001215200"},{"key":"10.1124\/jpet.103.058818_bib22","doi-asserted-by":"crossref","unstructured":"Niemi M, Backman JT, Neuvonen M, Neuvonen PJ, and Kivisto KT (2001) Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide. Clin Pharmacol Ther 69: 400\u2013406.","DOI":"10.1067\/mcp.2001.115822"},{"key":"10.1124\/jpet.103.058818_bib23","doi-asserted-by":"crossref","unstructured":"Rae JM, Johnson MD, Lippman ME, and Flockhart DA (2001) Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays. J Pharmacol Exp Ther 299: 849\u2013857.","DOI":"10.1016\/S0022-3565(24)29202-8"},{"key":"10.1124\/jpet.103.058818_bib24","doi-asserted-by":"crossref","unstructured":"Raucy JL (2003) Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products. Drug Metab Dispos 31: 533\u2013539.","DOI":"10.1124\/dmd.31.5.533"},{"key":"10.1124\/jpet.103.058818_bib25","doi-asserted-by":"crossref","unstructured":"Raucy JL, Mueller L, Duan K, Allen SW, Strom S, and Lasker JM (2002) Expression and induction of CYP2C P450 enzymes in primary cultures of human hepatocytes. J Pharmacol Exp Ther 302: 475\u2013482.","DOI":"10.1124\/jpet.102.033837"},{"key":"10.1124\/jpet.103.058818_bib26","doi-asserted-by":"crossref","unstructured":"Sueyoshi T and Negishi M (2001) Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. Annu Rev Pharmacol Toxicol 41: 123\u2013143.","DOI":"10.1146\/annurev.pharmtox.41.1.123"},{"key":"10.1124\/jpet.103.058818_bib27","doi-asserted-by":"crossref","unstructured":"Sullivan-Klose TH, Ghanayem BI, Bell DA, Zhang ZY, Kaminsky LS, Shenfield GM, Miners JO, Birkett DJ, and Goldstein JA (1996) The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism. Pharmacogenetics 6: 341\u2013349.","DOI":"10.1097\/00008571-199608000-00007"},{"key":"10.1124\/jpet.103.058818_bib28","doi-asserted-by":"crossref","unstructured":"Tirona RG, Lee W, Leake BF, Lan LB, Cline CB, Lamba V, Parviz F, Duncan SA, Inoue Y, Gonzalez FJ, Schuetz EG, and Kim RB (2003) The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat Med 9: 220\u2013224.","DOI":"10.1038\/nm815"},{"key":"10.1124\/jpet.103.058818_bib29","doi-asserted-by":"crossref","unstructured":"Wang H, Faucette S, Sueyoshi T, Moore R, Ferguson S, Negishi M, and LeCluyse EL (2003) A novel distal enhancer module regulated by pregnane X receptor\/constitutive androstane receptor is essential for the maximal induction of CYP2B6 gene expression. J Biol Chem 278: 14146\u201314152.","DOI":"10.1074\/jbc.M212482200"},{"key":"10.1124\/jpet.103.058818_bib30","doi-asserted-by":"crossref","unstructured":"Watkins RE, Maglich JM, Moore LB, Wisely GB, Noble SM, Davis-Searles PR, Lambert MH, Kliewer SA, and Redinbo MR (2003) 2.1 A crystal structure of human PXR in complex with the St. John\u2019s wort compound hyperforin. Biochemistry 42: 1430\u20131438.","DOI":"10.1021\/bi0268753"},{"key":"10.1124\/jpet.103.058818_bib31","doi-asserted-by":"crossref","unstructured":"Waxman DJ (1999) P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR and PPAR. Arch Biochem Biophys 369: 11\u201323.","DOI":"10.1006\/abbi.1999.1351"},{"key":"10.1124\/jpet.103.058818_bib32","doi-asserted-by":"crossref","unstructured":"Wentworth JM, Agostini M, Love J, Schwabe JW, and Chatterjee VK (2000) St John\u2019s wort, a herbal antidepressant, activates the steroid X receptor. J Endocrinol 166: R11\u2013R16.","DOI":"10.1677\/joe.0.166r011"},{"key":"10.1124\/jpet.103.058818_bib33","doi-asserted-by":"crossref","unstructured":"Williamson KM, Patterson JH, McQueen RH, Adams KF Jr, and Pieper JA (1998) Effects of erythromycin or rifampin on losartan pharmacokinetics in healthy volunteers. Clin Pharmacol Ther 63: 316\u2013323.","DOI":"10.1016\/S0009-9236(98)90163-1"},{"key":"10.1124\/jpet.103.058818_bib34","doi-asserted-by":"crossref","unstructured":"Xie W, Barwick JL, Simon CM, Pierce AM, Safe S, Blumberg B, Guzelian PS, and Evans RM (2000) Reciprocal activation of xenobiotic response genes by nuclear receptors SXR\/PXR and CAR. Genes Dev 14: 3014\u20133023.","DOI":"10.1101\/gad.846800"},{"key":"10.1124\/jpet.103.058818_bib35","doi-asserted-by":"crossref","unstructured":"Zelko I, Sueyoshi T, Kawamoto T, Moore R, and Negishi M (2001) The peptide near the C terminus regulates receptor CAR nuclear translocation induced by xenochemicals in mouse liver. Mol Cell Biol 21: 2838\u20132846.","DOI":"10.1128\/MCB.21.8.2838-2846.2001"},{"key":"10.1124\/jpet.103.058818_bib36","doi-asserted-by":"crossref","unstructured":"Zilly W, Breimer DD, and Richter E (1975) Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance. Eur J Clin Pharmacol 9: 219\u2013227.","DOI":"10.1007\/BF00614021"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524311504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524311504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.103.058818","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T14:43:51Z","timestamp":1739976231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524311504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0022356524311504"],"URL":"https:\/\/doi.org\/10.1124\/jpet.103.058818","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of Human CYP2C9 by Rifampicin, Hyperforin, and Phenobarbital Is Mediated by the Pregnane X Receptor","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.103.058818","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}